Skip to search formSkip to main contentSkip to account menu

AG7088

Known as: AG 7088, AG-7088 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

rupintrivir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Épocas de plantio e dose econômica de nitrogênio para o milho cultivado nos Tabuleiros Costeiros Alagoanos
Objetivou-se, com este trabalho, determinar a dose economica de adubacao nitrogenada para o milho em quatro epocas de cultivo. O… 
2007
2007
Development of potent inhibitors of the coxsackievirus 3C protease.
2005
2005
Lack of Respiratory and Contact Sensitizing Potential of the Intranasal Antiviral Drug Candidate Rupintrivir (AG7088): A Weight-of-the-Evidence Evaluation
Rupintrivir, also known as AG7088, is a small molecule 3C protease inhibitor designed to target human rhinovirus as a potential… 
2004
2004
Synthetic studies towards anti-SARS agents: application of an indium-mediated allylation of α-aminoaldehydes as the key step towards an intermediate
2004
2004
An efficient and tunable route to AG7088, a rhinovirus protease inhibitor
2004
2004
Discovery of anti‐SARS coronavirus drug based on molecular docking and database screening
Abstract The active site of 3CL proteinase (3CLpro) for coronavirus was identified by comparing the crystal structures of human… 
2001
2001
Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease.
In vitro metabolism of AG7088 [trans-(4S,2'R,5'S,3"'S)-4-[2'-4-(4-fluorobenzyl)-6'-methyl-5'-[(5"-methylisoxazole-3… 
2001
2001
LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY AND LIQUID CHROMATOGRAPHY-NMR CHARACTERIZATION OF IN VITRO METABOLITES OF A POTENT AND IRREVERSIBLE PEPTIDOMIMETIC INHIBITOR OF RHINOVIRUS 3 C PROTEASE
In vitro metabolism of AG7088 [trans-(4S,2*R,5*S,3-S)-4-{2*-4-(4fluorobenzyl)-6*-methyl-5*-[(5(-methylisoxazole-3(-carbonylamino… 
Review
2000
Review
2000
Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention
1999
1999
Viral proteases and phosphorodiesterase inhibitors.
  • P. Agathangelou
  • IDrugs : the investigational drugs journal
  • 1999
  • Corpus ID: 11630830
A number of novel drug candidates, which are at different stages of development and various therapeutic targets, mechanisms of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)